Showing results (761-770 of 4,513) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|February 9, 2022
Is the CyberKnife© radiosurgery system effective and safe for patients? An umbrella review of the evidenceYifan Cheng, Yifei Lin, Youlin Long, et al.
Future Oncology (London, England)|February 9, 2022
Low-dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain in palliative careAlbert Tuca Rodríguez, Miguel Núñez Viejo, Pablo Maradey, et al.
Future Oncology (London, England)|February 11, 2022
Factors associated with time to EGFR TKI treatment in patients with non-squamous metastatic non-small-cell lung cancerElizabeth Marrett, Winghan Jacqueline Kwong, Laura Qm Chow
Future Oncology (London, England)|January 27, 2022
Unmet needs in the treatment of intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangementsNina Beri
Future Oncology (London, England)|January 31, 2022
How we treat HR-positive, HER2-negative early breast cancerSara Lopez-Tarruella, Isabel Echavarria, Yolanda Jerez, et al.
Future Oncology (London, England)|February 2, 2022
Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequencesMichael J Burke, Beata Zalewska-Szewczyk
Future Oncology (London, England)|February 3, 2022
Real-world data on diffuse large B-cell lymphoma in 2010-2019: usability of large data sets of Finnish hospital data lakesSamuli Tuominen, Kristiina Uusi-Rauva, Tea Blom, et al.
Future Oncology (London, England)|February 2, 2022
Turalio risk evaluation and mitigation strategy for treatment of tenosynovial giant cell tumor: framework and experienceCharles Dharmani, Eric Wang, Maribel Salas, et al.
Future Oncology (London, England)|January 25, 2022
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrenceAlexander Mm Eggermont, Paolo A Ascierto, Nikhil I Khushalani, et al.
Future Oncology (London, England)|April 26, 2022
Ovarian failure risk in post-pubertal patients with cancer: a prognostic modelRaffaella Cioffi, Maria Luisa Fais, Alice Bergamini, et al.
Pageof 452